These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Activity of Cefiderocol Against Iregui A; Khan Z; Landman D; Quale J Microb Drug Resist; 2020 Jul; 26(7):722-726. PubMed ID: 32031915 [TBL] [Abstract][Full Text] [Related]
23. In Vitro Activity of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacilli Isolated from Patients in Canadian Intensive Care Units. Golden AR; Adam HJ; Baxter M; Walkty A; Lagacé-Wiens P; Karlowsky JA; Zhanel GG Diagn Microbiol Infect Dis; 2020 May; 97(1):115012. PubMed ID: 32081522 [TBL] [Abstract][Full Text] [Related]
24. Multilaboratory Comparison of Omadacycline MIC Test Strip to Broth Microdilution MIC against Gram-Negative, Gram-Positive, and Fastidious Bacteria. Koeth LK; DiFranco-Fisher JM; Hardy DJ; Palavecino EL; Carretto E; Windau A J Clin Microbiol; 2022 Jan; 60(1):e0141021. PubMed ID: 34613800 [TBL] [Abstract][Full Text] [Related]
25. Comparison of Disk Diffusion, E-Test, and Broth Microdilution Methods for Testing In Vitro Activity of Cefiderocol in Kolesnik-Goldmann N; Seth-Smith HMB; Haldimann K; Imkamp F; Roloff T; Zbinden R; Hobbie SN; Egli A; Mancini S Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508308 [TBL] [Abstract][Full Text] [Related]
26. Performance of discs, sensititre EUMDROXF microplates and MTS gradient strips for the determination of the susceptibility of multidrug-resistant Pseudomonas aeruginosa to cefiderocol. Devoos L; Biguenet A; Rousselot J; Bour M; Plésiat P; Fournier D; Jeannot K Clin Microbiol Infect; 2023 May; 29(5):652.e1-652.e8. PubMed ID: 36587736 [TBL] [Abstract][Full Text] [Related]
27. Characterisation of cefiderocol-non-susceptible Acinetobacter baumannii isolates from Taiwan. Yamano Y; Ishibashi N; Kuroiwa M; Takemura M; Sheng WH; Hsueh PR J Glob Antimicrob Resist; 2022 Mar; 28():120-124. PubMed ID: 34958997 [TBL] [Abstract][Full Text] [Related]
28. Skipped wells and scientific error during fosfomycin agar dilution and broth microdilution lead to inconsistent minimal inhibitory concentrations and may be cause for reevaluating testing methods for Bixby ML; Daley EC; Collins LB; Salay JM; Bryson AL; Hirsch EB Microbiol Spectr; 2024 Aug; 12(8):e0420523. PubMed ID: 38940588 [TBL] [Abstract][Full Text] [Related]
29. Performance evaluation of the UMIC® Cefiderocol to determine MIC in Gram-negative bacteria. Dortet L; Niccolai C; Pfennigwerth N; Frisch S; Gonzalez C; Antonelli A; Giani T; Hoenings R; Gatermann S; Rossolini GM; Naas T J Antimicrob Chemother; 2023 Jul; 78(7):1672-1676. PubMed ID: 37209112 [TBL] [Abstract][Full Text] [Related]
30. Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli. Hindler JA; Humphries RM J Clin Microbiol; 2013 Jun; 51(6):1678-84. PubMed ID: 23486719 [TBL] [Abstract][Full Text] [Related]
31. Assessment of cefiderocol disk diffusion versus broth microdilution results when tested against Liu Y; Ding L; Han R; Zeng L; Li J; Guo Y; Hu F Microbiol Spectr; 2023 Dec; 11(6):e0535522. PubMed ID: 37855593 [TBL] [Abstract][Full Text] [Related]
32. Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study design. Huband MD; Ito A; Tsuji M; Sader HS; Fedler KA; Flamm RK Diagn Microbiol Infect Dis; 2017 Jun; 88(2):198-200. PubMed ID: 28410852 [TBL] [Abstract][Full Text] [Related]
33. In vitro activity of cefiderocol, a siderophore cephalosporin, against a recent collection of clinically relevant carbapenem-non-susceptible Gram-negative bacilli, including serine carbapenemase- and metallo-β-lactamase-producing isolates (SIDERO-WT-2014 Study). Kazmierczak KM; Tsuji M; Wise MG; Hackel M; Yamano Y; Echols R; Sahm DF Int J Antimicrob Agents; 2019 Feb; 53(2):177-184. PubMed ID: 30395986 [TBL] [Abstract][Full Text] [Related]
34. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli. Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199 [TBL] [Abstract][Full Text] [Related]